Zhejiang Hisun Biomaterials Co.Ltd. (SHA:688203)
China · Delayed Price · Currency is CNY 18.95
-1.45 (-7.11%)
At close: Sep 30, 2026
SHA:688203 Revenue
Zhejiang Hisun Biomaterials Co.Ltd. had revenue of 338.77M CNY in the quarter ending June 30, 2026, with 67.02% growth. This brings the company's revenue in the last twelve months to 1.05B, up 27.64% year-over-year. In the year 2025, Zhejiang Hisun Biomaterials Co.Ltd. had annual revenue of 851.69M with 0.77% growth.
Revenue (ttm)
1.05B
Revenue Growth
+27.64%
P/S Ratio
3.62
Revenue / Employee
2.22M
Employees
472
Market Cap
3.80B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 851.69M | 6.50M | 0.77% |
| Dec 31, 2024 | 845.19M | 91.87M | 12.20% |
| Dec 31, 2023 | 753.32M | 147.88M | 24.43% |
| Dec 31, 2022 | 605.43M | 20.43M | 3.49% |
| Dec 31, 2021 | 585.01M | 322.34M | 122.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.